Department of Defense Offers Neurofibromatosis Clinical Trial Grant
SynopsisVersion HistoryRelated DocumentsPackage This grant, the Neurofibromatosis Research Program Clinical Trial Award, is for supporting innovative research designed to significantly advance the treatment and management of Neurofibromatosis (NF). It aims to fund clinical trials that evaluate promising new medical products, including pharmacologic agents (drugs or biologics), medical devices, and novel clinical guidance or emerging technologies. Projects can span the entire spectrum of clinical research, from small-scale proof-of-concept studies like pilot or [...]